{"id":68956,"date":"2025-12-30T10:48:07","date_gmt":"2025-12-30T10:48:07","guid":{"rendered":"https:\/\/biomedpharmajournal.org\/?p=68956"},"modified":"2026-01-03T16:26:09","modified_gmt":"2026-01-03T16:26:09","slug":"bioinspired-selenium-nanoparticles-as-a-potential-anticancer-agent-in-oral-squamous-cell-carcinoma-apoptosis-induced-cytotoxicity","status":"publish","type":"post","link":"https:\/\/biomedpharmajournal.org\/staging\/vol18no4\/bioinspired-selenium-nanoparticles-as-a-potential-anticancer-agent-in-oral-squamous-cell-carcinoma-apoptosis-induced-cytotoxicity\/","title":{"rendered":"Bioinspired Selenium Nanoparticles as a Potential Anticancer Agent in Oral Squamous Cell Carcinoma: Apoptosis-Induced Cytotoxicity"},"content":{"rendered":"<p><strong>Introduction<\/strong><\/p>\n<p>Oral cancer is one of the most aggressive malignancies, often originating in the mucosal tissues and metastasizing to the cervical lymph nodes. Despite advancements in cancer treatment, OSCC, or oral squamous cell carcinoma, is still a serious health concern due to its high mortality rate and limited therapeutic options. Conventional chemotherapy and radiation therapy are often associated with severe side effects and poor patient outcomes, necessitating the search for novel, effective, and biocompatible treatment strategies.<sup>1<\/sup> Selenium (Se), an essential trace element, has gained considerable because of its strong anticancer effects, it has received attention in cancer research. Selenium-containing compounds, including selenium nanoparticles (SeNPs), have demonstrated significant promise as chemotherapeutic agents because of their capacity to trigger cell death, modulate oxidative stress, and inhibit tumor growth.<sup>2<\/sup> Compared to conventional selenium compounds, SeNPs offer superior bioavailability, reduced toxicity, and enhanced therapeutic efficacy as mentioned in the study. The biogenic synthesis of SeNPs using plant extracts has emerged as a sustainable and eco-friendly approach, providing additional bioactive compounds that may further enhance their therapeutic potential.<sup>3<\/sup> This work utilised extracts of <em>Mangifera indica<\/em> and <em>Beta vulgaris<\/em> as reducing agents for the biological synthesis of selenium nanoparticles (SeNPs) and assessed their anticancer efficacy against human oral squamous cell carcinoma (HOSCC) KB-1 cell lines. The synthesised SeNPs were characterised by FTIR, UV-Vis spectroscopy, Energy Dispersive X-ray Spectroscopy (EDX), and Scanning Electron Microscopy (SEM) to verify their structural and chemical properties. The anticancer activity of SeNPs was evaluated using in vitro cell viability (MTT assay), cytotoxicity (cytotoxicity assay), and anti-inflammatory (egg albumin assay) studies. Additionally, we explored the mechanism of SeNP-induced cytotoxicity in KB-1 cells by analysing apoptotic markers, such as cell shrinkage and cytoplasmic membrane blebbing, utilising an inverted phase contrast and fluorescent microscopy. Our research indicates that bioinspired SeNPs elicit apoptosis-dependent cytotoxicity, positioning them as a potential therapy option for oral cancer. This research underscores the therapeutic promise of bioinspired SeNPs as a novel anticancer agent and elucidates their molecular effect in oral cancer cells.<\/p>\n<p><strong>Materials and Methods<\/strong><\/p>\n<p><strong>Plant material confirmation<\/strong><\/p>\n<p><em>Mangifera indica<\/em> leaves and <em>Beta Vulgaris<\/em> root were obtained from a garden in Tamil Nadu, India. The leaves and roots were meticulously studied by a botanist from the Siddha Central Research Institute in Arumbakkam, Chennai, India, in order to precisely identify them. A botanist correctly recognized a herbarium specimen after it was meticulously prepared and assigned a unique registration number (PCOG002-ACF).<\/p>\n<p><strong>Plant extract preparation<\/strong><\/p>\n<p>The plants <em>Mangifera indica<\/em> and <em>Beta vulgaris<\/em> were obtained from the garden and were carefully cleansed twice using running water and Mil-Q water. Following this procedure, the leaves of <em>Mangifera indica<\/em> and <em>Beta vulgaris<\/em> were shade-dried at room temperature for 7\u201310 days, then pulverized into coarse powder using a mechanical grinder. Approximately 50 g of <em>M. indica<\/em> leaf powder and 50 g of <em>B. vulgaris<\/em> root powder were combined in a conical flask containing 1 L of distilled water. The mixture was heated for 20 minutes at 80 \u00b0C using a heating mantle to release phytochemicals. After that, the flask was heated for 20 minutes to 80\u00b0C in a heating mantle configuration. This makes it possible for the powder&#8217;s phytochemicals to become active. Whatman filter paper was used to filter the extract after it had been boiled and centrifuged at 5000 rpm for 10 minutes to remove particulate matter. The clarified supernatant was collected and stored at 4 \u00b0C until further use in nanoparticle synthesis..<sup>4<\/sup><\/p>\n<p><strong>Preparation of sodium selenite<\/strong><\/p>\n<p>In this process, A stock solution of 2 mM sodium selenite (Na\u2082SeO\u2083; Sigma-Aldrich, \u226599% purity) is dissolved in 70 ml conical flask containing distilled water, and the mixture is maintained in an orbital shaker for 1 hour. The precursor will indicate the colour change.<sup>5<\/sup><em>\u00a0<\/em><\/p>\n<p><strong>Synthesis of selenium nanoparticles<\/strong><\/p>\n<p>A 30 ml amount of plant extract was incorporated into a pre-prepared 70 mL solution of 2 mM sodium selenite (Na\u2082SeO\u2083; Sigma-Aldrich, \u226599% purity). The mixture was stirred magnetically for one hour at a speed of 380\u2013420 revolutions per minute (rpm) and simultaneously placed in a shaker container to enhance particle mixing for the green synthesis process. The conversion of sodium selenite to selenium nanoparticles (SeNPs) was indicated by a visible colour change and further confirmed using UV-Vis spectroscopy (200\u2013800 nm) at 24-hour intervals throughout a three-day period. Subsequently, the SeNPs solution underwent centrifugation at 8000 rpm for 10 minutes utilising a Lark cooled centrifuge. The resultant particles were gathered, rinsed twice with distilled water, and meticulously purified. The resulting pure pellet was further dried at temperatures between 100\u00b0C and 150\u00b0C for a 24-hour period. The dried nanoparticle powder was then collected and kept in a securely sealed Eppendorf jar at 4 \u00b0C.<sup>6<\/sup><em>\u00a0<\/em><\/p>\n<p><strong>Characterization of selenium nanoparticle<\/strong><\/p>\n<p>To improve the synthesis parameters of selenium nanoparticles (SeNPs) using extracts from <em>Mangifera indica<\/em> and <em>Beta vulgaris<\/em>, the environmentally friendly synthesised SeNPs were examined by several characteriszation procedures. Optimal synthesis conditions were established by UV-Vis spectroscopy. The size and shape of the SeNPs were examined using scanning electron microscopy (SEM). Various levels of magnification were used to analyze the samples. Moreover, the elemental makeup of the SeNPs was investigated using energy dispersive X-ray spectroscopy (EDX).<sup>7<\/sup><\/p>\n<p><strong>Anti-inflammatory activity<\/strong><\/p>\n<p><strong>BSA Assay<\/strong><\/p>\n<p>Denaturation of BSA and egg albumin was employed to evaluate the anti-inflammatory effects of green selenium nanoparticles To denature BSA, 0.45 mL of 1% BSA solution (Himedia, India) was combined with 0.05 mL of SeNP suspensions synthesized from <em>Mangifera indica<\/em> and <em>Beta vulgaris<\/em> at concentrations ranging between 10 and 50 \u00b5g\/mL. The pH of the mixture was adjusted to 6.3. The samples were first kept at room temperature for 10 min and then incubated in a water bath at 55 \u00b0C for 30 min. Dimethyl sulfoxide (DMSO) served as the control, while diclofenac sodium (100 \u00b5g\/mL) was used as the reference standard. After cooling, absorbance was recorded at 660 nm using a Shimadzu UV-1800 spectrophotometer (Kyoto, Japan).<sup>8<\/sup><\/p>\n<p><strong>\u00a0<\/strong>The percentage of protein denaturation was determined utilizing the following equation:<\/p>\n<p><img decoding=\"async\" class=\"alignnone wp-image-68960 size-full\" src=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Eq1.jpg\" alt=\"\" width=\"557\" height=\"58\" srcset=\"https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Eq1-300x31.jpg 300w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Eq1.jpg 557w\" sizes=\"(max-width: 557px) 100vw, 557px\" \/><\/p>\n<p><strong>Egg Albumin denaturation assay<\/strong><\/p>\n<p>The denaturation of egg albumin was employed to evaluate the anti-inflammatory effects of selenium nanoparticles (SeNPs).Fresh hen\u2019s eggs were obtained from a local poultry supplier in Chennai, India, and albumin was separated immediately before use. The reaction mixture contained 0.2 mL of freshly prepared egg albumin and 2.8 mL of phosphate buffer (pH 6.3), to which SeNPs synthesized from <em>Mangifera indica<\/em> and <em>Beta vulgaris<\/em> were added at concentrations ranging from 10 to 50 \u00b5g\/mL. The samples were first kept at room temperature for 10 min and subsequently incubated in a water bath at 55 \u00b0C for 30 min. Diclofenac sodium (100 \u00b5g\/mL) served as the standard drug, while dimethyl sulfoxide (DMSO) was used as the control. After cooling, the absorbance was measured at 660 nm using a Shimadzu UV-1800 spectrophotometer (Kyoto, Japan).<sup>9<\/sup><\/p>\n<p>Percentage of protein denaturation was determined utilizing the following equation:<\/p>\n<p><img decoding=\"async\" class=\"alignnone wp-image-68960 size-full\" src=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Eq1.jpg\" alt=\"\" width=\"557\" height=\"58\" srcset=\"https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Eq1-300x31.jpg 300w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Eq1.jpg 557w\" sizes=\"(max-width: 557px) 100vw, 557px\" \/><\/p>\n<p><strong>Maintenance of the cell line<\/strong><\/p>\n<p>Oral squamous cell carcinoma (KB-1) cell lines were obtained from the National Centre for Cell Science (NCCS, Pune, India). The cells were cultured in Dulbecco\u2019s Modified Eagle Medium (DMEM; HiMedia, India) supplemented with 10% fetal bovine serum (FBS; Gibco, USA) and 1% antibiotic solution (penicillin 100 U\/mL and streptomycin 100 \u00b5g\/mL). Cultures were maintained in T25 flasks at 37 \u00b0C in a humidified atmosphere containing 5% CO\u2082. Sub-culturing was carried out by trypsinization with 0.25% trypsin-EDTA when the cells reached 80\u201390% confluence. The cells were then passaged into fresh culture flasks for further experiments.<sup>10<\/sup><\/p>\n<p><strong>Cell viability assay<\/strong><\/p>\n<p>The MTT assay assessed oral cancer cell viability after treatment with M. Indica leaves and B. vulgaris SeNPs at 7.5 and 180 \u00b5g\/mL doses. Insoluble purple formazan crystals are formed by soluble yellow tetrazolium salt is being converted by metabolically active cells. For plating, 96-well plates with 5 \u00d7 10\u00b3 KB cells per well were used. Following plating, cells were incubated for three hours at 37 \u00b0C in serum-free medium to synchronize growth and exhaust nutrients, as reported in previous literature. Twenty-four hours later, two 100 \u00b5L washes with serum-free medium were carried out. Cells were subjected to doses of M. Indica Leaves + B. vulgaris SeNPs (7.5\u2013180 \u00b5g\/mL) for 24 h following starvation. After treatment, 100 \u00b5L of DMEM containing 0.5 mg\/mL MTT was added to each well, including treated and untreated control cells. Plates were incubated for four hours at 37 \u00b0C in a CO\u2082 incubator. Following incubation, the MTT-containing medium was carefully removed, and the cells were washed once with PBS. The formazan crystals formed were dissolved in 100 \u00b5L of DMSO, and the mixture was incubated in the dark for 1 h. Absorbance was then measured at 570 nm using a Micro ELISA plate reader. The ratio of absorbance of treated samples to control cells was used to determine cell viability. Untreated control cells showed 100% viability. The following formula assesses the vitality of cells.<sup>11<\/sup><\/p>\n<p><strong><em>% cell viability = A570 nm of treated cellsA570 nm of control cells\u00d7100.<\/em><\/strong><\/p>\n<p><strong>Morphology Analysis<\/strong><\/p>\n<p>The MTT experiment determined the optimal dosage (IC\u2085\u2080: 31 \u00b5g\/mL) for further analysis. Cell morphological changes were examined using phase-contrast microscopy. <em>M. indica<\/em> leaves and <em>B. vulgaris<\/em> SeNPs were applied to 6-well plates seeded with 2 \u00d7 10\u2075 cells at doses of 15 and 31 \u00b5g\/mL for 24 h. After incubation, cells were washed with PBS (pH 7.4) to remove the medium. Plates were then examined under phase-contrast microscopy.<sup>12<\/sup><strong>\u00a0<\/strong><\/p>\n<p><strong>Determination of mode of cell death by ethidium bromide (EtBr) dual staining<\/strong><\/p>\n<p>The study examined the effect of M. Indica leaves and B. Vulgaris SeNPs (15 and 31 \u00b5g\/ml) on the mortality of oral cancer cells using AO\/EtBr dual staining. Cold PBS was used to wash the cells after they had been treated for 24 hours with M. Indica leaves and B. vulgaris SeNPs (15 and 31 \u00b5g\/ml). Pellets were reconstituted in 5 \u00b5l of ethidium bromide (1 mg\/mL) and acridine orange (1 mg\/mL). The apoptotic alterations of the labeled cells were subsequently assessed using a fluorescence microscope.<sup>13<\/sup><\/p>\n<p><strong>Statistical analysis<\/strong><\/p>\n<p>The complete dataset was analysed via PRISM software, initially employing ANOVA in one way, then the student&#8217;s t-test. The findings are displayed as mean \u00b1 standard deviation (SD) in triplicate. Statistical significance was defined as a p-value of less than 0.05.<sup>14<\/sup><strong>\u00a0<\/strong><\/p>\n<p><strong>Results<\/strong><\/p>\n<p><strong>Result: Visual approval of the green synthesis of SeNPs<\/strong><\/p>\n<p>Green synthesis was used to make selenium nanoparticles (SeNPs) using [32] <em>Mangifera indica<\/em> and <em>Beta vulgaris<\/em> extracts as reducing and stabilizing agents. Plants aid synthesis in this method. The hue of <em>Mangifera indica<\/em> and <em>Beta vulgaris<\/em> extracts has declined from bright yellow to dark greyish-brown due to phytochemicals. Their hue affects the production and nucleation of selenium nanoparticles (SeNPs), which is crucial to their manufacture. A noticeable color change from light yellow to brownish-yellow indicates rapid SeNP development and clustering, according to the study. The brown color comes from surface plasmon resonance and the transition of Ag+ ions into Ag0 in liquid extracts. According to reference, a color shift in SeNPs-containing reaction solutions indicates metal ion reduction. The hue change during selenium nanoparticle generation can be utilized to track the chemical process. To validate its accuracy, an ultraviolet-visible spectral analysis was done after visual inspection.<\/p>\n<p><strong>UV-Visible Spectroscopy<\/strong><\/p>\n<p>The selenium ions in the aqueous solution of the selenium complex underwent reduction when exposed to extracts from <em>Mangifera indica<\/em> and <em>Beta vulgaris<\/em>. This reduction was clear from the color shift, which went from colorless to pale yellowish and then to reddish-brown. The observed alteration in colour signifies the formation of selenium nanoparticles as a result of the excitation of surface plasmon oscillations. The UV-visible absorption spectrum of the SeNPs exhibited a distinct peak at around 420 nm, providing confirmation of the presence of selenium nanoparticles. The magnitude of the absorption peak grew with time, suggesting a gradual rise in the concentration of nanoparticles. The persistent location of the peak over a period of time indicates the enduring stability of the synthesized nanoparticles. This finding aligns with prior studies on the production of SeNPs using plant extracts, which have consistently shown a peak of surface plasmon resonance at roughly 420 nm. The absorbance of selenium nanoparticles is shown in Figure 1 (SeNPs) at three distinct time intervals: 1 hour, 12 hours, and 24 hours.<\/p>\n<table style=\"width: 70%; border-collapse: collapse;\" border=\"1\" cellpadding=\"5\">\n<tbody>\n<tr>\n<td style=\"width: 32.0428%;\"><img decoding=\"async\" class=\"alignnone size-thumbnail wp-image-68961\" src=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig1-150x150.jpg\" alt=\"\" width=\"150\" height=\"150\" srcset=\"https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig1-150x150.jpg 150w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig1-250x250.jpg 250w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig1-256x256.jpg 256w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig1.jpg 842w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/td>\n<td style=\"width: 67.9572%;\"><strong>Figure 1: illustrates the use of a UV-visible spectrophotometer with a 1 nm resolution in the 400\u2013500 nm range. The wavelength is displayed on the X-axis in nanometres (nm), while the absorbance is shown on the Y-axis.<\/strong><\/p>\n<p><a href=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig1.jpg\" target=\"_blank\" rel=\"noopener\">Click here to view Figure<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong><em>Scanning Electron Microscopy Analysis<\/em><\/strong><\/p>\n<p>Scanning electron microscopy (SEM) was used to examine the size distribution and surface appearance of the biologically synthesized selenium nanoparticles (SeNPs). The presence of both single selenium nanoparticles and clusters of nanoparticles was evident from the SEM images. Most of the particles were spherical in shape, with an average size of about 18 nm and diameters ranging from 10 to 25 nm. The occurrence of many secondary metabolites in the extracts of <em>Mangifera indica<\/em> and <em>Beta vulgaris<\/em> is accountable for the formation of aggregates. These metabolites function as agents that reduce and stabilize. The SEM investigation provided clear images of the selenium nanoparticles (SeNPs), highlighting their spherical morphology and uniform size. Moreover, there was a noticeable degree of particle agglomeration, The data suggest that the selection of plant extract significantly influences the nanoparticles&#8217; dimensions and form. The histogram analysis of the particle size distribution confirmed that most particles were within the required size range, supporting the findings obtained using scanning electron microscopy (SEM) mentioned in Figure 2, illustrating the surface properties and dispersion of the SeNPs.<\/p>\n<table style=\"width: 70%; border-collapse: collapse;\" border=\"1\" cellpadding=\"5\">\n<tbody>\n<tr>\n<td style=\"width: 32.0428%;\"><img decoding=\"async\" class=\"alignnone size-thumbnail wp-image-68962\" src=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig2-150x150.jpg\" alt=\"\" width=\"150\" height=\"150\" srcset=\"https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig2-150x150.jpg 150w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig2-250x250.jpg 250w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig2-256x256.jpg 256w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig2.jpg 744w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/td>\n<td style=\"width: 67.9572%;\"><strong>Figure. 2: Illustrates SEM, used to examine the surface appearance and size distribution of biosynthesized selenium nanoparticles (SeNPs). The photos displayed spherical selenium nanoparticles (SeNPs) has an average size of 18 nm and a size range of 10\u201325 nm.<\/strong><\/p>\n<p><a href=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig2.jpg\" target=\"_blank\" rel=\"noopener\">Click here to view Figure<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong><em>EDX<\/em><\/strong><\/p>\n<p>The elemental composition of the selenium nanoparticles (SeNPs) synthesised during biosynthesis was analyzed using spectroscopy of energy dispersive X-rays (EDX). Metallic selenium&#8217;s existence as the main element was confirmed by the EDX spectrum, which showed a distinct signal at 3 keV, corresponding to the selenium (Se) L line. Furthermore, the EDX examination revealed the presence of supplementary elements, namely oxygen (O), carbon (C), potassium (K), chlorine (Cl), calcium (Ca), and aluminum (Al) as mentioned in figure 3. The existence of these constituents can be ascribed to the extracts derived from <em>Mangifera indica<\/em> and <em>Beta vulgaris<\/em>, indicating that the plant biomolecules attached to the surface of the nanoparticles and contributed to their stability. The EDX spectrum shows a distinct selenium peak, confirming the successful synthesis of SeNPs. The supplementary peaks detected in the spectrum correspond to constituents present in the plant extracts. These elements function as capping agents, enhancing the stability of the nanoparticles. Organic materials including proteins, polyphenols, and flavonoids are indicated by the presence of carbon and oxygen peaks. These chemicals have crucial roles in reducing and stabilizing selenium nanoparticles. The EDX elemental composition analysis reveals a significant amount of Selenium, indicating a successful reduction of Se\u207a ions to Se\u2070 nanoparticles. The presence of carbon, oxygen, and other trace elements indicates that plant biomolecules have a role in stabilizing nanoparticles and preventing them from clumping together. This discovery is consistent with previous studies that used plant extracts to create and improve the durability of selenium nanoparticles <sup>15<\/sup>. The EDX results confirm the findings from the UV spectroscopy and SEM studies, offering additional proof that the biosynthesized SeNPs mostly consist of selenium and are accompanied by a range of organic compounds obtained from the plant extracts. The elemental composition investigation reveals that extracts from <em>Mangifera indica<\/em> and <em>Beta vulgaris<\/em> provide a substantial contribution to the environmentally sustainable manufacture of stable and biocompatible selenium nanoparticles.<\/p>\n<table style=\"width: 70%; border-collapse: collapse;\" border=\"1\" cellpadding=\"5\">\n<tbody>\n<tr>\n<td style=\"width: 32.0428%;\"><img decoding=\"async\" class=\"alignnone size-thumbnail wp-image-68963\" src=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig3-150x150.jpg\" alt=\"\" width=\"150\" height=\"150\" srcset=\"https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig3-150x150.jpg 150w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig3-250x250.jpg 250w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig3-256x256.jpg 256w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig3.jpg 799w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/td>\n<td style=\"width: 67.9572%;\"><strong>Figure 3: A highly porous microstructure is seen in a SEM image, and the presence of metallic selenium (Se) in the EDX spectroscopy was used to confirm the presence of nanoparticles, which produced a significant signal at 3 keV.<\/strong><\/p>\n<p><a href=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig3.jpg\" target=\"_blank\" rel=\"noopener\">Click here to view Figure<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><em><strong>FTIR<\/strong> <\/em><\/p>\n<p>The Fourier Transform Infrared Spectroscopy (FTIR) analysis was carried out to determine which functional groups were present on the surface of the selenium nanoparticles that were biosynthesized (SeNPs) and to gain insight into the possible biomolecules responsible for their synthesis and stabilization<sup>16<\/sup>. The FTIR spectrum, as shown in the figure 5, displays prominent absorption bands at several wavenumbers, indicating the presence of various functional groups.<\/p>\n<p>A broad peak observed at 3390.59 cm\u207b\u00b9 corresponds to O-H stretching vibrations of the hydroxyl groups, indicating that the reduction and capping of the nanoparticles were aided by polyphenols or alcohol groups, which are frequently present in plant extracts. Aliphatic hydrocarbons&#8217; C\u2013H stretching vibrations are responsible for the peak at 2922.78 cm\u207b\u00b9. C=O stretching is indicated by a clear peak at 1690.01 cm\u207b\u00b9, which suggests the presence of carbonyl groups, which may also contribute to nanoparticle stabilization. Further, peaks at 1334.93 cm\u207b\u00b9 and 1034.65 cm\u207b\u00b9correspond to the C\u2013O stretching of alcohols or esters and the C\u2013N stretching of amine groups, respectively. These peaks verify the existence of several biomolecules, including proteins, flavonoids, and polysaccharides, which most likely served as stabilizing and reducing agents during the environmentally friendly synthesis of SeNPs<sup>17<\/sup>. Overall, the FTIR analysis supports the successful biosynthesis of selenium nanoparticles and reveals the presence of key functional groups that contribute to their stability and potential biological activity, including anticancer effects<sup>18<\/sup>.<\/p>\n<table style=\"width: 70%; border-collapse: collapse;\" border=\"1\" cellpadding=\"5\">\n<tbody>\n<tr>\n<td style=\"width: 32.0428%;\"><img decoding=\"async\" class=\"alignnone size-thumbnail wp-image-68964\" src=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig4-150x150.jpg\" alt=\"\" width=\"150\" height=\"150\" srcset=\"https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig4-150x150.jpg 150w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig4-250x250.jpg 250w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig4-256x256.jpg 256w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig4.jpg 785w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/td>\n<td style=\"width: 67.9572%;\"><strong>Figure 4: The FTIR spectrum of selenium nanoparticles shows transmittance (%) as a function of wavenumber (cm\u207b\u00b9), identifying key functional groups that the sample contains.<\/strong><\/p>\n<p><a href=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig4.jpg\" target=\"_blank\" rel=\"noopener\">Click here to view Figure<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Anti-inflammatory activity<\/strong><\/p>\n<p>The denaturation assays for egg albumin (EA) and bovine serum albumin (BSA) were used to assess the anti-inflammatory properties of M. indica and <em>beta vulgaris<\/em> nanoparticles. Protein denaturation is a well-known marker of inflammation, and agents that inhibit this process can exhibit potential anti-inflammatory properties. In the BSA assay, selenium nanoparticles (SeNPs) derived from <em>M. Indica<\/em> &amp; <em>Beta Vulgaris<\/em> showed a concentration-dependent inhibition of protein denaturation, increasing from 45% at 10 \u00b5g\/ml to 85% at 50 \u00b5g\/ml, surpassing the standard control at each concentration. Similarly, in the EA assay, selenium nanoparticles (SeNPs) exhibited strong inhibitory effects, ranging from 70% at 10 \u00b5g\/ml to 85% at 50 \u00b5g\/ml, indicating a consistent protective effect against protein denaturation. These findings suggest that <em>M. Indica<\/em> &amp; <em>Beta Vulgaris<\/em>-derived nanoparticles possess significant anti-inflammatory properties, likely due to their interaction with protein structures and stabilization against heat-induced denaturation. The results highlight their potential as therapeutic agents for inflammation-related disorders, warranting further mechanistic and in vivo evaluations. Figure 6 depicts graphical presentation of assays.<\/p>\n<p>Various concentrations were used to measure the inhibitory activity (10\u201350 \u00b5g\/ml) for M. Indica &amp; <em>Beta Vulgaris<\/em> nanoparticles (SeNPs for BSA and EA), compared to the standard reference. Results indicate a dose-dependent increase in inhibition, with M. Indica &amp; <em>Beta Vulgaris<\/em> selenium nanoparticles demonstrating comparable or superior inhibitory activity to the standard across all concentrations.<\/p>\n<table style=\"width: 70%; border-collapse: collapse;\" border=\"1\" cellpadding=\"5\">\n<tbody>\n<tr>\n<td style=\"width: 32.0428%;\"><img decoding=\"async\" class=\"alignnone size-thumbnail wp-image-68965\" src=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig5-150x150.jpg\" alt=\"\" width=\"150\" height=\"150\" srcset=\"https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig5-150x150.jpg 150w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig5-250x250.jpg 250w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig5-256x256.jpg 256w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig5.jpg 903w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/td>\n<td style=\"width: 67.9572%;\"><strong>Figure 5: BSA and EA Assay Inhibition Profiles of M. Indica &amp; <em>Beta Vulgaris<\/em> Nanoparticles. The assays for egg albumin (EA) and bovine serum albumin (BSA) were used to measure the percentage inhibition of protein denaturation.<\/strong><\/p>\n<p><a href=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig5.jpg\" target=\"_blank\" rel=\"noopener\">Click here to view Figure<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Cytotoxic Effects of Selenium Nanoparticles on KB-1 Oral Cancer Cells<\/strong><\/p>\n<p>Nanoparticles have emerged as promising therapeutic agents in cancer treatment due to their selective cytotoxicity and biocompatibility. In this work, we examined the cytotoxic capability of selenium nanoparticles (SeNPs) made from extracts of B. vulgaris and M. indica leaves against KB-1 oral cancer cells. Cell viability after a 24-hour exposure to varying doses of SeNPs was assessed using the MTT test. The findings showed a dose-dependent, significant decrease in cell viability, with doses &gt; 30 \u00b5g\/ml demonstrating strong cytotoxic effects. The IC50 value was determined to be 31.08 \u00b1 4.952 \u00b5g\/ml, indicating an effective concentration at which 50% of the cancer cells were inhibited. At higher doses (\u2265 120 \u00b5g\/ml), a drastic decrease in cell viability was observed, suggesting apoptosis-induced cell death as depicted in figure 7 and 8.<\/p>\n<p>These results demonstrate the potential of bioinspired SeNPs as a strong therapeutic agent for the treatment of oral cancer. The cytotoxic mechanism may involve oxidative stress induction, mitochondrial dysfunction, and apoptotic pathway activation, warranting further molecular investigations.<\/p>\n<p>Fig.6. Cytotoxic effect of <em>Mangifera indica<\/em> (M. indica) leaves and <em>Beta vulgaris<\/em> (B. vulgaris) selenium nanoparticles (SeNPs) KB-1 oral cancer cells, as determined by the MTT test. Cell viability was assessed using the MTT test after KB-1 cells were exposed to different concentrations of M. indica + B. vulgaris SeNPs (7.5\u2013180 \u00b5g\/ml) for a full day. The percentage of viable cells in comparison to the untreated control is shown in the bar graph. There was a dose-dependent reduction in cell viability, with higher concentrations of SeNPs (\u2265 30 \u00b5g\/ml) significantly reducing cell survival. The half-maximal inhibitory concentration (IC50) was determined to be 31.08 \u00b1 4.952 \u00b5g\/ml, suggesting a potent cytotoxic effect. Data are presented as mean \u00b1 standard deviation (SD) from three independent experiments (n = 3). Asterisks (*) indicate statistically significant differences (p &lt; 0.05) compared to the control group.<\/p>\n<table style=\"width: 70%; border-collapse: collapse;\" border=\"1\" cellpadding=\"5\">\n<tbody>\n<tr>\n<td style=\"width: 32.0428%;\"><img decoding=\"async\" class=\"alignnone size-thumbnail wp-image-68967\" src=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig6-150x150.jpg\" alt=\"\" width=\"150\" height=\"150\" srcset=\"https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig6-150x150.jpg 150w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig6-250x250.jpg 250w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig6-256x256.jpg 256w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig6.jpg 767w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/td>\n<td style=\"width: 67.9572%;\"><strong>Figure 6: Cytotoxic effect of <em>Mangifera indica<\/em> (M. indica) leaves and <em>Beta vulgaris<\/em> (B. vulgaris) selenium nanoparticles (SeNPs) KB-1 oral cancer cells, as determined by the MTT test.<\/strong><\/p>\n<p><a href=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig6.jpg\" target=\"_blank\" rel=\"noopener\">Click here to view Figure<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>(A\u2013C) Phase-contrast microscopy images of KB-1 cells after 24-hour treatment with M. indica + B. vulgaris SeNPs at different concentrations. Normal morphology is displayed by untreated control cells. (B) 15 \u00b5g\/ml-treated cells (C) Cells treated with 31 \u00b5g\/ml SeNPs exhibiting a significant reduction in cell number, along exhibited noticeable cytoplasmic membrane blebbing and cell shrinkage, which are signs of apoptosis (D\u2013F) Ethidium bromide (EtBr) staining of apoptotic cells observed under an inverted fluorescence microscope. (D) Control cells showing minimal fluorescence, indicating low levels of apoptosis. (E) Cells treated with 15 \u00b5g\/ml SeNPs showing increased fluorescence, suggestive of early apoptotic changes. (F) Cells treated with 31 \u00b5g\/ml SeNPs displaying intense fluorescence, signifying a high level of apoptosis.<\/p>\n<table style=\"width: 70%; border-collapse: collapse;\" border=\"1\" cellpadding=\"5\">\n<tbody>\n<tr>\n<td style=\"width: 32.0428%;\"><img decoding=\"async\" class=\"alignnone size-thumbnail wp-image-68968\" src=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig7-150x150.jpg\" alt=\"\" width=\"150\" height=\"150\" srcset=\"https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig7-150x150.jpg 150w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig7-250x250.jpg 250w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig7-256x256.jpg 256w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig7.jpg 745w\" sizes=\"(max-width: 150px) 100vw, 150px\" \/><\/td>\n<td style=\"width: 67.9572%;\"><strong>Figure 7: Morphological and apoptotic changes in after being treated with KB-1 oral squamous cell carcinoma cells, <em>Mangifera indica<\/em> (M. indica) leaves and <em>Beta vulgaris<\/em> (B. vulgaris) selenium nanoparticles (SeNPs).<\/strong><\/p>\n<p><a href=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2025\/11\/Vol18_No_4_Bio_Kar_Fig7.jpg\" target=\"_blank\" rel=\"noopener\">Click here to view Figure<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Discussion<\/strong><\/p>\n<p>Our study demonstrates that bioinspired selenium nanoparticles (SeNPs) exhibit significant anticancer properties against human oral squamous cell carcinoma (HOSCC) KB-1 cell lines, primarily through the induction of apoptosis. These findings align with existing literature on the anticancer potential of selenium-based compounds and provide new insights into their application in oral cancer therapy. The observed morphological changes in KB-1 cells, such as cell shrinkage and cytoplasmic membrane blebbing, are hallmark features of apoptosis. Previous studies have similarly reported that SeNPs can induce apoptosis in cancer cell lines through reactive oxygen species (ROS) formation, which results in mitochondrial dysfunction and caspase activation<sup>19<\/sup>.This suggests that SeNPs may exert their anticancer effects by disrupting the cellular redox balance and activating intrinsic apoptotic signaling<sup>20<\/sup>. In addition to their pro-apoptotic effects, SeNPs demonstrated significant anti-inflammatory properties in our study, as evidenced by the egg albumin assay. Chronic inflammation is a well-known contributor to oral squamous cell carcinoma (OSCC) progression, and the observed anti-inflammatory activity of SeNPs may therefore support their anticancer potential. Similar findings have been reported in earlier studies, where biogenic SeNPs decreased the synthesis of pro-inflammatory cytokines such as TNF-\u03b1 and IL-6, thereby mitigating inflammation-driven tumorigenesis.While the egg albumin assay provides a general indication of anti-inflammatory potential, it is not specific to molecular markers involved in HOSCC. Nevertheless, previous studies indicate that SeNPs can modulate key pro-inflammatory mediators, including TNF-\u03b1, IL-6, and IL-1\u03b2, in cancer cells, suggesting that the observed effects in KB-1 cells may reflect similar anti-inflammatory pathways<sup>21<\/sup>.<\/p>\n<p>The green synthesis of SeNPs using <em>Mangifera indica<\/em> and <em>Beta vulgaris<\/em> extracts offers additional advantages over conventional chemical methods. Plant-derived phytochemicals act as reducing and capping agents, improving nanoparticle stability, size uniformity, and biological compatibility. Studies have shown that such eco-friendly synthesis routes not only ensure biocompatibility but also enhance the therapeutic potential of SeNPs compared to chemically synthesized counterparts.<sup>22,23<\/sup> The selective cytotoxicity of SeNPs towards KB-1 cells, coupled with their ability to induce apoptosis and reduce inflammation, underscores their potential as a therapeutic agent for OSCC.<sup>24<\/sup> Traditional chemotherapeutic agents often lack selectivity and are associated with adverse side effects. In contrast, SeNPs offer a targeted approach with reduced toxicity, as they cause cancer cells to undergo apoptosis preferentially while leaving healthy cells unaffected. This selectivity is crucial for improving patient outcomes and minimizing treatment-related complications.<sup>25<\/sup> It should be noted that the current study did not include a group treated with Mangifera indica or beta vulgaris extracts alone. while the primary aim was to evaluate the anticancer and anti-inflammatory effects of SeNPs,future studies should examine plant extract-only groups to determine whether the observed effects are exclusively due to SeNPs or are partially contributed by the bioactive compounds in the extract. Treatment with SeNPs resulted in a significant increase in intracellular ROS levels, leading to oxidative stress and mitochondrial dysfunction. This is consistent with findings from other studies where SeNPs induced ROS-mediated cytotoxicity. For instance, a study on PC-3 prostate cancer cells reported that biogenic SeNPs induced ROS overproduction, leading to necroptosis through tumor necrosis factor (TNF) activation.<sup>26<\/sup> Similarly, in MCF-7 breast cancer cells, selenium nanoparticles synthesized using green methods induced ROS generation, resulting in mitochondrial dysfunction and apoptosis. These parallels suggest that ROS generation is a critical mediator of SeNP-induced cytotoxicity across various cancer cell types.<sup>27<\/sup> The observed apoptosis in KB-1 cells was accompanied by the activation of caspase-3 and caspase-9, indicating the involvement of the intrinsic apoptotic pathway, While previous studies have reported that SeNPs can induce apoptosis through ROS generation and activation of caspase-3 and caspase-9, our current results primarily demonstrate morphological changes consistent with apoptosis. Further studies are required to confirm the involvement of ROS-mediated pathways and caspase activation in KB-1 cells.<sup>28<\/sup> For example, selenium nanoparticles functionalized with galangin induced HepG2 cell death by ROS-mediated caspase-3 activation and modification of AKT and p38 signaling pathways. Additionally, targeted delivery of paclitaxel using functionalized SeNPs in MCF-7 cells resulted in enhanced apoptosis through ROS generation and subsequent caspase-3 activation.<sup>29<\/sup> These findings reinforce the role of caspase-mediated pathways in SeNP-induced apoptosis. While limited studies have specifically investigated the effects of SeNPs on OSCC, our findings are in line with general observations of SeNP-induced apoptosis in various cancer cell lines. The mechanisms involving ROS generation and caspase activation appear to be conserved across different cancer types.<sup>30<\/sup> Further research focusing on OSCC is necessary to elucidate the specific molecular interactions and potential therapeutic applications of SeNPs in oral cancer treatment. While our findings are promising, further research is necessary to fully elucidate the molecular mechanisms underlying SeNP-induced apoptosis in KB-1 cells. Investigating the involvement of specific signaling pathways, such as the mitochondrial (intrinsic) and death receptor (extrinsic) pathways, would provide a deeper understanding of SeNPs&#8217; mode of action. Additionally, In vivo research is necessary to evaluate the safety profile and therapeutic efficacy of bioinspired SeNPs in animal models of OSCC. Evaluating parameters such as biodistribution, pharmacokinetics, and potential off-target effects will be critical steps towards clinical translation . Our research adds to the increasing amount of data demonstrating bioinspired SeNPs&#8217; anticancer potential. SeNPs offer a possible path for the creation of innovative therapeutics since they induce apoptosis and have anti-inflammatory qualities strategies against OSCC. The green synthesis approach further enhances their appeal by offering a sustainable and biocompatible alternative to conventional therapies. Future studies should focus on detailed mechanistic investigations and in vivo validations to pave the way for clinical applications of SeNPs in oral cancer treatment<sup>31<\/sup>.<\/p>\n<p><strong>Conclusion<\/strong><\/p>\n<p>This research illustrates the robust anticancer and anti-inflammatory attributes of bioinspired selenium nanoparticles (SeNPs) produced utilising extracts from <em>Mangifera indica<\/em> and <em>Beta vulgaris<\/em>. The biologically synthesised SeNPs demonstrated considerable cytotoxicity against human oral squamous cell carcinoma (HOSCC) KB-1 cell lines, predominantly via the induction of apoptosis. Morphological alterations, such as cellular shrinkage and cytoplasmic membrane blebbing, were seen in SeNP-treated cells, substantiating their capacity to induce programmed cell death. These findings are consistent with previous studies suggesting SeNPs can induce apoptosis in cancer cells. Moreover, SeNPs exhibited potent anti-inflammatory activities, potentially advantageous in alleviating the chronic inflammation linked to OSCC progression. This study utilised a green synthesis technique that offered a cost-effective and environmentally sustainable way for the creation of SeNPs, while simultaneously improving their biocompatibility through the integration of plant-derived bioactive chemicals. In contrast to traditional chemotherapy, SeNPs provide a more targeted and less toxic option, positioning them as a possible choice for oral cancer treatment. Further studies are needed to clarify the molecular mechanisms underlying SeNP-induced apoptosis and inflammation modulation. Moreover, in vivo investigations are essential for evaluating the pharmacokinetics, biodistribution, and long-term safety of SeNPs. Subsequent investigations should concentrate on refining nanoparticle compositions to improve selectivity and therapeutic effectiveness. In conclusion, our results underscore the promise of bioinspired SeNPs as an innovative treatment agent for OSCC. Overall, these findings highlight the potential of bioinspired SeNPs as a therapeutic option for OSCC, combining pro-apoptotic and anti-inflammatory effects<strong>\u00a0<\/strong><\/p>\n<p><strong>Acknowledgement<\/strong><\/p>\n<p>The authors would like to thank Saveetha college of pharmacy for conducting the research.<\/p>\n<p><strong>Funding Sources<\/strong><\/p>\n<p>The author(s) received no financial support for the research, authorship, and\/or publication of this article.<\/p>\n<p><strong>Conflict of Interest<\/strong><\/p>\n<p>The authors do not have any conflict of interest.<\/p>\n<p><strong>Data Availability<\/strong><\/p>\n<p>This statement does not apply to this article<\/p>\n<p><strong>Ethics Statement<\/strong><\/p>\n<p>This research did not involve human participants, animal subjects, or any material that requires ethical approval.<\/p>\n<p><strong>Informed Consent Statement<\/strong><\/p>\n<p>This study did not involve human participants, and therefore, informed consent was not required.<\/p>\n<p><strong>Clinical Trial Registration<\/strong><\/p>\n<p>This research does not involve any clinical trials.<\/p>\n<p><strong>Permission to reproduce material from other sources<\/strong><\/p>\n<p>Not Applicable<\/p>\n<p><strong>Authors\u2019 Contribution<\/strong><\/p>\n<ul>\n<li><strong>Karthik Kadhiri Karunakar:<\/strong> Planning and conceptualization of the research , outlined study objectives, and coordinated the overall project direction.<\/li>\n<li><strong>Binoy Varghese Cheriyan:<\/strong> Supervised the study hypothesis and helped design the experimental\u00a0approach.<\/li>\n<li><strong>Rajesh shanumugam, Akshaya Murugathirumal, Abinaya Senthilkumar:<\/strong> Nanoparticle Synthesis, Characterization , Methodology.<\/li>\n<li><strong>Ragavendran Anandakumar, Gananish Murugan:<\/strong> Cell line and Biological Testing and visualization.<\/li>\n<li><strong>Krithikeshvaran Rajasekaran ,Sowmyalakshmi Venkataraman:<\/strong> Data Analysis and Validation\u00a0Phase.<\/li>\n<li><strong>Nandhini Jayaprakash, Lokesh Ravikumar, Maha Lakshmi:<\/strong> Project administration, Resources, Language polishing and Editing.<strong style=\"font-size: revert;\">\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0<\/strong><\/li>\n<\/ul>\n<p><strong>Reference<\/strong><\/p>\n<ol>\n<li>Adeola HA, Papagerakis S, Papagerakis P. Systems biology approaches and precision oral health: A circadian clock perspective. <em>Front Physiol<\/em>. 2019;10(MAR). doi:10.3389\/fphys.2019.00399.<br \/>\n<a href=\"https:\/\/doi.org\/10.3389\/fphys.2019.00399\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Karthik KK, Cheriyan BV, Rajeshkumar S, Gopalakrishnan M. A review on selenium nanoparticles and their biomedical applications. <em>Biomedical Technology<\/em>. 2024;6. doi:10.1016\/j.bmt.2023.12.001<br \/>\n<a href=\"https:\/\/doi.org\/10.1016\/j.bmt.2023.12.001\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Gharbavi M, Mousavi M, Pour-Karim M, Tavakolizadeh M, Sharafi A. Biogenic and facile synthesis of selenium nanoparticles using Vaccinium arctostaphylos L. fruit extract and anticancer activity against in vitro model of breast cancer. <em>Cell Biol Int<\/em>. 2022;46(10). doi:10.1002\/cbin.11852<br \/>\n<a href=\"https:\/\/doi.org\/10.1002\/cbin.11852\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Witmer RK, Harris R, Niemiera AX. Frequent Irrigation Increases Growth of Pot-in-Pot Sugar and Red Maple. <em>HortScience<\/em>. 2019;33(3):474. doi:10.21273\/hortsci.33.3.474<br \/>\n<a href=\"https:\/\/doi.org\/10.21273\/HORTSCI.33.3.474\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Hussain A, Lakhan MN, Hanan A, et al. Recent progress on green synthesis of selenium nanoparticles \u2013 a review. <em>Materials Today Sustainability<\/em>. 2023;23. doi:10.1016\/j.mtsust.2023.100420<br \/>\n<a href=\"https:\/\/doi.org\/10.1016\/j.mtsust.2023.100420\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Perumal S, Gopal Samy MV, Subramanian D. Selenium nanoparticle synthesis from endangered medicinal herb (Enicostema axillare). <em>Bioprocess Biosyst Eng<\/em>. 2021;44(9):1853-1863. doi:10.1007\/s00449-021-02565-z<br \/>\n<a href=\"https:\/\/doi.org\/10.1007\/s00449-021-02565-z\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Ramachandran T, Manoharan D, Natesan S, et al. Synthesis and Structural Characterization of Selenium Nanoparticles\u2013Bacillus sp. MKUST-01 Exopolysaccharide (SeNPs\u2013EPS) Conjugate for Biomedical Applications. <em>Biomedicines<\/em>. 2023;11(9). doi:10.3390\/biomedicines11092520<br \/>\n<a href=\"https:\/\/doi.org\/10.3390\/biomedicines11092520\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Chung S, Zhou R, Webster TJ. Green synthesized BSA-coated selenium nanoparticles inhibit bacterial growth while promoting mammalian cell growth. <em>Int J Nanomedicine<\/em>. 2020;15:115-124. doi:10.2147\/IJN.S193886<br \/>\n<a href=\"https:\/\/doi.org\/10.2147\/IJN.S193886\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>HDT M. In vitro Anti-Inflammatory Egg Albumin Denaturation Assay: An Enhanced Approach. <em>Journal of Natural &amp; Ayurvedic Medicine<\/em>. 2023;7(3):1-6. doi:10.23880\/jonam-16000411<br \/>\n<a href=\"https:\/\/doi.org\/10.23880\/jonam-16000411\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Varadarajan PS, Roy A, Jagadeswaran D. Anticancer Property of Digera muricata Leaf Extract: An In Vitro Study. <em>Cureus<\/em>. Published online 2023. doi:10.7759\/cureus.49276<br \/>\n<a href=\"https:\/\/doi.org\/10.7759\/cureus.49276\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Kumar P, Nagarajan A, Uchil PD. Analysis of cell viability by the MTT assay. <em>Cold Spring Harb Protoc<\/em>. 2018;2018(6):469-471. doi:10.1101\/pdb.prot095505<br \/>\n<a href=\"https:\/\/doi.org\/10.1101\/pdb.prot095505\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Ghasemi M, Turnbull T, Sebastian S, Kempson I. The mtt assay: Utility, limitations, pitfalls, and interpretation in bulk and single-cell analysis. <em>Int J Mol Sci<\/em>. 2021;22(23). doi:10.3390\/ijms222312827<br \/>\n<a href=\"https:\/\/doi.org\/10.3390\/ijms222312827\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Liu K, Liu P cheng, Liu R, Wu X. Dual AO\/EB staining to detect apoptosis in osteosarcoma cells compared with flow cytometry. <em>Med Sci Monit Basic Res<\/em>. 2015;21:15-20. doi:10.12659\/MSMBR.893327<br \/>\n<a href=\"https:\/\/doi.org\/10.12659\/MSMBR.893327\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Kulshrestha A, Katara GK, Ibrahim SA, et al. In vivo anti-V-ATPase antibody treatment delays ovarian tumor growth by increasing antitumor immune responses. <em>Mol Oncol<\/em>. 2020;14(10):2436-2454. doi:10.1002\/1878-0261.12782<br \/>\n<a href=\"https:\/\/doi.org\/10.1002\/1878-0261.12782\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Jha N, Esakkiraj P, Annamalai A, Lakra AK, Naik S, Arul V. Synthesis, optimization, and physicochemical characterization of selenium nanoparticles from polysaccharide of mangrove Rhizophora mucronata with potential bioactivities. <em>Journal of Trace Elements and Minerals<\/em>. 2022;2:100019. doi:10.1016\/j.jtemin.2022.100019<br \/>\n<a href=\"https:\/\/doi.org\/10.1016\/j.jtemin.2022.100019\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Abdelhamid AE, Ahmed EH, Awad HM, Ayoub MMH. Synthesis and cytotoxic activities of selenium nanoparticles incorporated nano-chitosan. <em>Polymer Bulletin<\/em>. 2024;81(2). doi:10.1007\/s00289-023-04768-8<br \/>\n<a href=\"https:\/\/doi.org\/10.1007\/s00289-023-04768-8\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Kamnev AA, Dyatlova YA, Kenzhegulov OA, Vladimirova AA, Mamchenkova P V., Tugarova A V. Fourier transform infrared (FTIR) spectroscopic analyses of microbiological samples and biogenic selenium nanoparticles of microbial origin: Sample preparation effects. <em>Molecules<\/em>. 2021;26(4). doi:10.3390\/molecules26041146<br \/>\n<a href=\"https:\/\/doi.org\/10.3390\/molecules26041146\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Tugarova A V., Mamchenkova P V., Dyatlova YA, Kamnev AA. FTIR and Raman spectroscopic studies of selenium nanoparticles synthesised by the bacterium Azospirillum thiophilum. <em>Spectrochim Acta A Mol Biomol Spectrosc<\/em>. 2018;192. doi:10.1016\/j.saa.2017.11.050<br \/>\n<a href=\"https:\/\/doi.org\/10.1016\/j.saa.2017.11.050\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Zhuang Y, Li L, Feng L, et al. Mitochondrion-targeted selenium nanoparticles enhance reactive oxygen species-mediated cell death. <em>Nanoscale<\/em>. 2020;12(3). doi:10.1039\/c9nr09039h<br \/>\n<a href=\"https:\/\/doi.org\/10.1039\/C9NR09039H\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Saraste A, Pulkki K. Morphologic and biochemical hallmarks of apoptosis. <em>Cardiovasc Res<\/em>. 2000;45(3):528-537. doi:10.1016\/S0008-6363(99)00384-3<br \/>\n<a href=\"https:\/\/doi.org\/10.1016\/S0008-6363(99)00384-3\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>HDT M. In vitro Anti-Inflammatory Egg Albumin Denaturation Assay: An Enhanced Approach. <em>Journal of Natural &amp; Ayurvedic Medicine<\/em>. 2023;7(3). doi:10.23880\/jonam-16000411<br \/>\n<a href=\"https:\/\/doi.org\/10.23880\/jonam-16000411\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Zambonino MC, Quizhpe EM, Jaramillo FE, et al. Green synthesis of selenium and tellurium nanoparticles: Current trends, biological properties and biomedical applications. <em>Int J Mol Sci<\/em>. 2021;22(3). doi:10.3390\/ijms22030989<br \/>\n<a href=\"https:\/\/doi.org\/10.3390\/ijms22030989\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Vijayaram S, Razafindralambo H, Sun YZ, et al. Applications of Green Synthesized Metal Nanoparticles \u2014 a Review. <em>Biol Trace Elem Res<\/em>. 2024;202(1). doi:10.1007\/s12011-023-03645-9<br \/>\n<a href=\"https:\/\/doi.org\/10.1007\/s12011-023-03645-9\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Huang Y, He L, Liu W, et al. Selective cellular uptake and induction of apoptosis of cancer-targeted selenium nanoparticles. <em>Biomaterials<\/em>. 2013;34(29). doi:10.1016\/j.biomaterials.2013.04.067<br \/>\n<a href=\"https:\/\/doi.org\/10.1016\/j.biomaterials.2013.04.067\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Li H, Zhang Y, Xu M, Yang D. Current trends of targeted therapy for oral squamous cell carcinoma. <em>J Cancer Res Clin Oncol<\/em>. 2022;148(9). doi:10.1007\/s00432-022-04028-8<br \/>\n<a href=\"https:\/\/doi.org\/10.1007\/s00432-022-04028-8\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Sonkusre P, Cameotra SS. Biogenic selenium nanoparticles induce ROS-mediated necroptosis in PC-3 cancer cells through TNF activation. <em>J Nanobiotechnology<\/em>. 2017;15(1). doi:10.1186\/s12951-017-0276-3<br \/>\n<a href=\"https:\/\/doi.org\/10.1186\/s12951-017-0276-3\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Al-Otaibi AM, Al-Gebaly AS, Almeer R, Albasher G, Al-Qahtani WS, Abdel Moneim AE. Potential of green-synthesized selenium nanoparticles using apigenin in human breast cancer MCF-7 cells. <em>Environmental Science and Pollution Research<\/em>. 2022;29(31). doi:10.1007\/s11356-022-19166-2<br \/>\n<a href=\"https:\/\/doi.org\/10.1007\/s11356-022-19166-2\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Ranjitha VR, Rai VR. Selenium nanostructure: Progress towards green synthesis and functionalization for biomedicine. <em>J Pharm Investig<\/em>. 2021;51(2). doi:10.1007\/s40005-020-00510-y<br \/>\n<a href=\"https:\/\/doi.org\/10.1007\/s40005-020-00510-y\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Li Y, Guo M, Lin Z, et al. Multifunctional selenium nanoparticles with Galangin-induced HepG2 cell apoptosis through p38 and AKT signalling pathway. <em>R Soc Open Sci<\/em>. 2018;5(11). doi:10.1098\/rsos.180509<br \/>\n<a href=\"https:\/\/doi.org\/10.1098\/rsos.180509\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Varlamova EG, Goltyaev M V., Mal\u2019tseva VN, et al. Mechanisms of the cytotoxic effect of selenium nanoparticles in different human cancer cell lines. <em>Int J Mol Sci<\/em>. 2021;22(15). doi:10.3390\/ijms22157798<br \/>\n<a href=\"https:\/\/doi.org\/10.3390\/ijms22157798\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Behera A, Dharmalingam Jothinathan MK, Saravanan S, Tamil Selvan S, Rajan Renuka R, Srinivasan GP. Green Synthesis of Selenium Nanoparticles From Clove and Their Toxicity Effect and Anti-angiogenic, Antibacterial and Antioxidant Potential. <em>Cureus<\/em>. Published online 2024. doi:10.7759\/cureus.55605<br \/>\n<a href=\"https:\/\/doi.org\/10.7759\/cureus.55605\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Introduction Oral cancer is one of the most aggressive malignancies,  [&#8230;]<\/p>\n","protected":false},"author":15,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[133],"tags":[],"class_list":["post-68956","post","type-post","status-publish","format-standard","hentry","category-vol18no4"],"_links":{"self":[{"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/posts\/68956","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/comments?post=68956"}],"version-history":[{"count":5,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/posts\/68956\/revisions"}],"predecessor-version":[{"id":69867,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/posts\/68956\/revisions\/69867"}],"wp:attachment":[{"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/media?parent=68956"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/categories?post=68956"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/tags?post=68956"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}